Franklin Biotechnology Discv A(acc)SGD

Performance History30/06/2017
Growth of 1,000 (ZAR)
Franklin Biotechnology Discv A(acc)SGD
Fund102.648.940.5-27.39.2
+/-Cat7.64.8-3.11.6-4.3
+/-Idx-4.44.4-3.7-4.9-1.1
 
Key Stats
NAV
26/07/2017
 SGD 31.98
Day Change 0.54%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0320765992
Fund Size (Mil)
30/06/2017
 USD 2408.64
Share Class Size (Mil)
30/06/2017
 SGD 26.03
Max Initial Charge 5.75%
Ongoing Charge
27/01/2017
  1.83%
Investment Objective: Franklin Biotechnology Discv A(acc)SGD
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns26/07/2017
YTD13.37
3 Years Annualised16.08
5 Years Annualised29.18
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Steven Kornfeld
15/09/2015
Inception Date
25/10/2007
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology PR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Discv A(acc)SGD30/06/2017
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks96.460.0096.46
Bonds0.000.000.00
Cash2.310.002.31
Other1.230.001.23
Top 5 Regions%
United States97.12
Middle East0.83
United Kingdom0.69
Eurozone0.58
Canada0.48
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare9.69
Alexion Pharmaceuticals IncHealthcareHealthcare7.67
Incyte CorpHealthcareHealthcare5.88
Regeneron Pharmaceuticals IncHealthcareHealthcare5.56
Biogen IncHealthcareHealthcare4.75
Franklin Biotechnology Discv A(acc)SGD